Back to Search
Start Over
Supplementary Table 2 from Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I–Modified Peptides
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- PDF file - 56K, Number of IFNγ-forming spots/2 � 105 CD8+ T cells in APL-vaccinated patients
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....13c98ee596d4776193ec16e580ec602e
- Full Text :
- https://doi.org/10.1158/1078-0432.22456064